0513-4870
2009 Issue 3
duo ba dian yao wu yan jiu zhuan kan zhu bian zhi ci
wang xiao liang
wang xiao liang
..............page:2
..............page:209-218
Small interfering RNA mediated multi-target therapy of cancer
shao rong guang
shao rong guang
..............page:219-225
Multi-target therapeutics and new drug discovery
xu yan ; li xue jun
xu yan ; li xue jun
..............page:226-230
..............page:230
Controlling arachidonic acid metabolic network: from single-to multi-target inhibitors of key enzymes
liu ying ; chen zheng ; shang er chang ; yang kun ; wei deng guo ; zhou zuo ; jiang xiao sheng ; he chong ; lai lu hua
liu ying ; chen zheng ; shang er chang ; yang kun ; wei deng guo ; zhou zuo ; jiang xiao sheng ; he chong ; lai lu hua
..............page:231-241
The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase Ⅲ
wu wen ; lu cheng ; chen si yu ; yu nie fang
wu wen ; lu cheng ; chen si yu ; yu nie fang
..............page:242-257
Progress in the research on multi-target-directed drugs against Alzheimer’s disease
liu zuo zuo ; lv qiu jun
liu zuo zuo ; lv qiu jun
..............page:258-263
Recent advance in the study of novel anti-tumor targets and drugs——aurora kinase and Pin1
chen xiao guang ; zhang yi
chen xiao guang ; zhang yi
..............page:264-269
Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets
hao hai ping ; zheng chao ; wang guang ji
hao hai ping ; zheng chao ; wang guang ji
..............page:270-275
Design of multiple targeted drugs
guo yan shen ; guo zong ru
guo yan shen ; guo zong ru
..............page:276-281
The multi-target drugs and their design
jiang feng chao
jiang feng chao
..............page:282-287
The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS
cao zuo ; you qi dong ; li zhi yu ; guo qing long ; yang yong ; shang jing ; yan ming ; chen ji wang ; chen meng ling
cao zuo ; you qi dong ; li zhi yu ; guo qing long ; yang yong ; shang jing ; yan ming ; chen ji wang ; chen meng ling
..............page:288-295
Synergic effects of the combination of VEGF-targeted shRNA and Taxol on human prostate cancer DU145 both in vitro and in vivo
li bao wei ; zhang min ; he hong wei ; zhang sheng hua ; shao rong guang
li bao wei ; zhang min ; he hong wei ; zhang sheng hua ; shao rong guang
..............page:296-302
2009 nian du quan guo yi yao xue shu jiao liu hui zuo lin chuang yao xue yu yao xue fu wu yan jiu jin zhan pei xun ban tong zhi
zhong guo yao li xue hui ; yi yao dao bao bian ji bu
zhong guo yao li xue hui ; yi yao dao bao bian ji bu
..............page:302
Design, synthesis and 5-HT/NE dual reuptake inhibitory activity of aromatic heterocyclic arylamidine derivatives
wen hui ; yang jing ; zhang jian jun ; wang ya fang ; ji cheng xue ; yang guang zhong
wen hui ; yang jing ; zhang jian jun ; wang ya fang ; ji cheng xue ; yang guang zhong
..............page:303-308
zhong guo yao xue za zhi dao jin bei di jiu jie quan guo yao wu fen xi you xiu lun wen ping xuan jiao liu hui zheng wen tong zhi
zhong guo yao xue hui yao wu fen xi zhuan ye wei yuan hui ; zhong guo yao xue za zhi bian ji bu
zhong guo yao xue hui yao wu fen xi zhuan ye wei yuan hui ; zhong guo yao xue za zhi bian ji bu
..............page:308
A novel cell model targeted on GLP-1 receptor for application to anti-diabetic candidates screening
huan zuo ; shen zhu fang
huan zuo ; shen zhu fang
..............page:309-313
Comparative pharmacophore analysis of dual dopamine D2/5-HT2A receptor antagonists
guo yan shen ; guo zong ru
guo yan shen ; guo zong ru
..............page:314-320
Synthesis and cardioprotective effect of a novel anti-ischemic / reperfused injury compound
liu wen chong ; sun xiao li ; ji le le ; wang hai bo ; zhang hai feng ; li jia ; shi lei ; jing lin lin ; gao feng
liu wen chong ; sun xiao li ; ji le le ; wang hai bo ; zhang hai feng ; li jia ; shi lei ; jing lin lin ; gao feng
..............page:321-326